SAINT VALERIEN CALICIVIRUS (VALOVIRUS)

LEVELS: No evidence of transmission;No evidence of transmission;Farm biosecurity effective;Difficult: poor recognition and diagnostics;Limited losses (few pigs);Little market disruption;Low resistance risk;Minimal: Rare or short-course individual treatments;No effective treatments;No effective vaccine or bacterin available;Extremely difficult and with uncertain success rate


OVERVIEW

Saint Valerien virus (SVV) is a recently described porcine calicivirus belonging to the genus Valovirus. It has been detected serologically and molecularly in pigs in multiple countries, but its role in clinical disease remains unknown.


FOODBORNE ZOONOTIC TRANSMISSION POTENTIAL

Level: No evidence of transmission

No evidence of foodborne zoonotic transmission.


NON-FOODBORNE ZOONOTIC TRANSMISSION POTENTIAL

Level: No evidence of transmission

No evidence of zoonotic transmission via occupational or environmental exposure.


DISEASE SPREAD BEYOND FARM BIOSECURITY CONTROL

Level: Farm biosecurity effective

Limited data exist; transmission is presumed pig-associated with no strong evidence of external amplification.


DIFFICULTY OF DETECTING AND CONFIRMING INFECTION

Level: Difficult: poor recognition and diagnostics

Detection relies on specialised molecular and serological tools primarily used in research contexts.


FINANCIAL IMPACT ON COST OF PRODUCTION

Level: Limited losses (few pigs)

No demonstrated association with clinical disease or production loss.


EFFECT ON DOMESTIC OR EXPORT MARKETS

Level: Little market disruption

No market or trade relevance.


PATHOGEN'S ABILITY TO DEVELOP AND SPREAD RESISTANCE

Level: Low resistance risk

Viral pathogen with no AMR relevance.


AMR DEVELOPMENT DRIVEN BY DISEASE MANAGEMENT

Level: Minimal: Rare or short-course individual treatments

Does not drive antimicrobial use.


AVAILABILITY OF EFFECTIVE TREATMENT OPTIONS

Level: No effective treatments

No treatments available or needed.


AVAILABILITY OF EFFECTIVE VACCINES OR BACTERINS

Level: No effective vaccine or bacterin available

No vaccines exist.


CAN THIS DISEASE BE ERADICATED FROM THE US?

Level: Extremely difficult and with uncertain success rate

Widespread exposure and uncertain disease relevance make eradication unrealistic.